GW3965 hydrochloride 100 mg | Purity Not Available
TargetMol
GW3965 hydrochloride (GW3965 HCl) is an effective and specific LXR agonist for hLXRα/β (EC50: 190/30 nM).
More Information Supplier PageGW3965 hydrochloride
Search Results
GW3965 hydrochloride 10 mg | Purity Not Available
TargetMol
GW3965 hydrochloride (GW3965 HCl) is an effective and specific LXR agonist for hLXRα/β (EC50: 190/30 nM).
More Information Supplier PageGW3965 hydrochloride
GW3965 hydrochloride 5 mg | Purity Not Available
TargetMol
GW3965 hydrochloride (GW3965 HCl) is an effective and specific LXR agonist for hLXRα/β (EC50: 190/30 nM).
More Information Supplier PageGW3965 hydrochloride
Allitinib tosylate 10 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate
Allitinib tosylate 25 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate
Allitinib tosylate 50 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate
Allitinib tosylate 5 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate
(S)-crizotinib 5 mg | Purity Not Available
TargetMol
(S)-crizotinib (ent-crizotinib) （IC50 of 72 nM）, an effective MTH1 (NUDT1) inhibitor, is the (S)-enantiomer of crizotinib.
More Information Supplier Page(S)-crizotinib
(R)-(-)-Gossypol acetic acid 10 mg | 96.73%
TargetMol
AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.32 μM, 0.48 μM and 0.18 μM; does not inhibit BIR3 domain and BID. Phase 2.
More Information Supplier Page(R)-(-)-Gossypol acetic acid
Bromosporine 5 mg | 99.65%
TargetMol
Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.
More Information Supplier PageBromosporine
